Clinical trial

Dietary Sugar Absorptive Phenotype for Prediction of Weight Loss Outcome

Invitation only · Not applicable · 1 countries · Registry ID NCT05408728

Invitation onlyNot applicableObservational

What this study is about

This study is trying to determine whether the success of bariatric surgery can be predicted by evaluating the dietary sugar absorptive characteristics in the small intestine and if there is any gene expression change on the dietary sugar absorptive characteristics.

A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.

Basic eligibility

Age18 Years to Not listed
SexAll
Healthy volunteersAccepted
ConditionObese, Healthy, Bariatric Surgery Candidate

Full registry criteria

Inclusion Criteria: \- Obese patients (BMI ≥ 30) scheduled for BS undergoing standard of care screening EGD, or lean BS-naïve individuals (BMI ≤ 25) subjected to EGD for routine clinical indications as part of standard care. Exclusion Criteria: * Adults unable to consent, including non-English speakers. * Pregnant women because endoscopy is a risk factor. All patients of childbearing age undergo history as well as urine pregnancy test as a standard of care prior to undergoing endoscopy as the procedure is performed under anesthesia. * Prisoners. * Subjects with preexisting conditions (e.g., bleeding at the time of the procedure, suspected perforation during the standard-of-care procedure) will be excluded from the study at the time of the endoscopy. * Have a contraindication to endoscopy. * A history of surgery on the stomach or small intestine. * Type 1 diabetes (clinical diagnosis and/or positive glutamic acid decarboxylase antibodies). * Using weight loss medications. * Active malignancy within the last 5 years.

Treatments and study arms

Endoscopic biopsy

Procedure

Upper small intestinal biopsies from patients undergoing BS will be collected during routine standard of care screening EGD and again from the same patients at 1 year during routine standard of care surveillance EGD (esophageal reflux screening/surveillance). Biopsy-derived enteroid cultures and tissue samples from pre- and one-year post BS will be examined for expression level of sugar transporters and gluconeogenic enzymes; glucose and fructose absorption

Primary outcomes

Number of obese patients with altered dietary sugar hyper-absorptive phenotype after bariatric surgery18 months

Study locations

1 locations were listed when this page was built. The first 40 are shown.

Mayo Clinic Florida🇺🇸 Jacksonville, Florida, United States